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Abstract hnRNPs H, HP and F belong to a subfamily of the
hnRNPs sharing a high degree of sequence identity. Eukaryotic
expression and specific C-terminal antibodies were used to
demonstrate great variation in the intracellular fate of the
proteins. hnRNPs H and HP become posttranslational cleaved
into C-terminal 35 kDa proteins (HC, HPC) and possibly into N-
terminal 22 kDa proteins. No detectable cleavage was observed
for hnRNP F. hnRNP H/HP is almost exclusively localized to the
nucleus of many cell types while hnRNP F varies from a
predominant nuclear localization in some cells to a predominant
cytoplasmic localization in other cells. The different fates may
reflect differences in functional roles that so far only have
included nuclear functions. The presence of significant quantities
of hnRNP F in the cytoplasm of many cells indicates that it also
may have a functional role here.
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1. Introduction
The heterogeneous nuclear ribonucleoproteins (hnRNPs)
constitute a family of more than 20 proteins designated with
letters from A to U [1]. The proteins are characterized by
having a modular structure possessing one or more RNA
binding domains together with one or more auxiliary domains
that may mediate protein-protein interactions. Isoforms of
some of the hnRNPs derive by alternative splicing of their
pre-mRNA while other hnRNPs are reported to undergo var-
ious forms of posttranslational modi¢cations. Of the several
RNA binding motifs occurring among these proteins the most
common is the RNA recognition motif (RRM) [2] consisting
of about 90 amino acids with two consensus sequences, an
octapeptide sequence, RNP-1, and a hexapeptide sequence,
RNP-2.
Recently, we and others [3^5] have identi¢ed a subfamily of
the hnRNPs consisting of hnRNP H, HP, F and 2H9 charac-
terized by a slightly di¡erent structure of the RRM domains
that have tentatively been termed quasi-RRMs (qRRMs) until
the three-dimensional structure has been more ¢rmly de-
termed [4]. The hnRNPs are mainly involved in the metabo-
lism of pre-mRNA [1]. The speci¢c functions of the individual
members are, however, unknown in detail. So far, only nu-
clear functions have been reported for hnRNPs H, HP, F and
2H9 where hnRNP H and hnRNP HP are part of the nuclear
matrix proteins [6] and stimulate pre-mRNA cleavage and
polyadenylation [7]. hnRNP H is a component of a splicing
enhancer complex [8] and participates in alternative splicing
[9]. hnRNP F participates in pre-mRNA splicing [10] and
interacts with the nuclear cap binding protein complex,
CBC [10,11] and hnRNP 2H9 acts in the splicing process
and also participates in early heat shock-induced splicing ar-
rest by transiently leaving the hnRNP complex [5].
For further functional studies it is important to have anti-
bodies speci¢c to each of the proteins. Due to the high degree
of sequence identity among the members of this subfamily
previous antibodies have not been able to distinguish between
hnRNPs H/HP and F [3,4]. Here we have raised antibodies
against C-terminal peptides of hnRNP H/HP and F and ana-
lyzed the intracellular fate of the proteins in cultured cells as
well as in various normal and pathological tissues. We show
that, in spite of the high degree of sequence similarity among
the proteins, hnRNP H/HP but not hnRNP F is subjected to
posttranslational proteolytic cleavage and that the subcellular
localization of hnRNP H/HP is very di¡erent from hnRNP F
in a number of tissues. The di¡erences in fate between the
proteins likely represent di¡erences in their functions.
2. Materials and methods
2.1. Culturing of cells and labelling with L-[35S]-methionine and
L-[35S]-cysteine
MRC-5 [12], MRC-5 V2 [13] and COS-1 [14] cells were grown as
monolayer cultures in Dulbecco’s modi¢ed Eagle’s medium (DMEM)
with GlutaMAX I supplemented with 10% (vol/vol) fetal bovine se-
rum and antibiotics (penicillin at 100 units/ml and streptomycin at 100
Wg/ml) from Life Technologies. Labelling of cells in vivo with L-[35S]-
methionine and L-[35S]-cysteine was performed in labelling medium
constructed by mixing 2.5 ml of DMEM (Life Technologies), 41.5
ml DMEM without methionine, cysteine and glutamine (Sigma), 0.5
ml GlutaMAX I Supplement (Life Technologies), 5 ml dialyzed fetal
bovine serum (Life Technologies) and 0.5 ml penicillin/streptomycin
(Life Technologies). Labelling was performed in this medium with the
addition of 0.1 mCi/ml of Pro-mix (SJQ 0079) from Amersham.
2.2. Production of antibodies against hnRNP H/HP and F
Peptides for immunization were obtained from Neosystem (Stras-
bourg, France). Two peptides were synthesized: peptide SP961010,
VLQENSSDFQSNIA corresponding to the 14 C-terminal amino
acids, Val436-Ala449, in hnRNP H (anti-H/HP) and peptide
SP961174, KRAAQATYSGLESQSV corresponding to 14 internal
amino acids, Ala384-Val397, at the C-terminal of hnRNP F (anti-F)
with the addition of Lys-Arg in the N-terminal. Both peptides were
coupled to keyhole limpet hemocyanin and injected in female rabbits
(2^2.5 kg) purchased from the State Serum Institute, Copenhagen,
Denmark. Immunization was performed essentially as described [15].
The animals were bled by vein puncture and non-speci¢c sera were
puri¢ed, ¢rst on a protein A column and then on a column with
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immobilized peptide. The antibody was eluted with 0.1 M glycine
bu¡er (pH 2.7) and neutralized with 1 M Tris-HCl, pH 9. Peptides
were immobilized by coupling to cyanogen bromide-activated EAH
Sepharose 4B according to the manufacturer’s description (Pharma-
cia, Sweden).
2.3. Eukaryotic and prokaryotic expression of hnRNPs
For eukaryotic expression the cDNAs encoding hnRNP H and HP
[4] were ampli¢ed by PCR with Pfu polymerase using the following
primers in case of hnRNP H: CAC-CTC-GAG-CGT-CTT-AGC-
CAC-GCA-GAA (3.1H(F) with a XhoI site) and TTC-GGA-TCC-
TTA-TGC-AAT-GTT-TGA-TTG-AAA (3.1H(R) with a BamHI
site) and in case of hnRNP HP : CAC-GGA-TCC-GGT-ATC-GTT-
AGA-GCT-ACA (3.1HP(F) with a BamHI site) and TTC-AAG-CTT-
AAG-CAA-GGT-TTG-ACT-GAT-A (hnRNPHP.R with a HindIII
site). The PCR products were cut with the appropriate restriction
enzymes, puri¢ed on low temperature gelling agarose and ligated
into pcDNA3.1/Zeo(-) (Invitrogen, San Diego, CA, USA) cut with
identical restriction enzymes. The constructs were grown in large scale
and puri¢ed by the alkaline lysate method [16] followed by ultracen-
trifugation in a CsCl gradient. All constructs were sequenced in order
to check for correct orientation and sequence of the inserts. COS-1 or
MRC-5 V2 cells grown in 3 cm Petri dishes containing one coverslip
were transfected overnight in DMEM without penicillin and strepto-
mycin with 2 Wg of the vector constructs using LipofectAMIN (Life
Technologies). Next day the medium was exchanged with labelling
medium. After 48 h the cells were rinsed with PBS (2.7 mM KCl,
1.8 mM KH2PO4, 10.1 mM Na2HPO4, 140 mM NaCl, pH 7.3) and
harvested with a police rubberman. Proteins were extracted into phe-
nol and precipitated with ethanol. The precipitated proteins were pel-
leted by centrifugation, vacuum dried and ¢nally dissolved in lysis
bu¡er for subsequent analysis by two-dimensional gel electrophoresis.
For prokaryotic expression the cDNA encoding hnRNP F was
ligated into the pT7-PL vector by PCR ampli¢cation essentially as
described [4]. Transformation of Escherichia coli cells, expression
and puri¢cation of recombinant hnRNP F protein was performed
essentially as described [17].
2.4. Two-dimensional gel electrophoresis
Two-dimensional gel electrophoresis was performed in the ¢rst di-
mension by using Immobiline DryStrip immobilized pH gradients, 3^
10 non-linear (Pharmacia, Uppsala, Sweden) and in the second dimen-
sion SDS polyacrylamide gel electrophoresis. To each sample was
added rehydration solution (8 M urea, 2% CHAPS, 0.5% IPG bu¡er
pH 3^10 NL, 0.3% DTT, Bromphenol Blue) to a ¢nal volume of
approximately 400 Wl. Each rehydration solution with sample was
pipetted into a slot of the reswelling tray (Pharmacia) together with
an Immobiline DryStrip gel and left overnight. Electrophoresis in the
¢rst dimension was run on a Multiphor II £at bed unit essentially
according to the manufacturer (Pharmacia). For the second dimension
home-made horizontal polyacrylamide gels were used. After electro-
phoresis the gels were dried and exposed with Kodak X-ray ¢lms.
2.5. Immunoblotting
Gels were placed for 10 min in 25 mM Tris-HCl, 190 mM glycine,
and 20% methanol, and proteins transferred to nitrocellulose or poly-
vinylidene di£uoride (PVDF) membranes. For immunodetection of
the antigen the nitrocellulose sheets were incubated for at least 2 h
at room temperature in PBS bu¡er (2.7 mM KCl, 1.8 mM KH2PO4,
10.1 mM Na2HPO4, 140 mM NaCl, pH 7.0) containing 0.05% Tween-
20 and 5% skim milk. The membranes were washed shortly in PBS
with 0.05% Tween-20. The ¢rst antibody was added and incubated for
a 1 h period. After three washes in PBS with Tween-20, the blots were
incubated for another hour with peroxidase-conjugated swine anti-
rabbit IgG from DAKO (dilution 1:5000). Finally, the membranes
were washed three times (3U10 min) in PBS with Tween-20 and
developed by the enhanced chemiluminescence (ECL) technique
(Amersham).
2.6. Immunohistochemistry
Slides containing a variety of normal and pathological human tissue
sections, formalin ¢xed and para⁄n embedded were depara⁄nized for
1 h at 60^65‡C and rehydrated in consecutive baths containing xylen
(3U5 min) and graded ethanol, 99% (3U5 min), 96% (2U5 min) and
70% (1U5 min) and ¢nally for 5 min in PBS (80.9 mM Na2HPO4,
21.5 mM NaH2PO4, 0.1 M NaCl, pH 7.5). Then they were washed in
PBS with 50 mM NH4Cl (3U10 min) and for at least 5 min in baths
containing graded ethanol; 30%, 50%, 75%, 90%, 100%, 90%, 75%,
50%, 30%, before washing in PBS with 1% BSA, 0.05% saponin and
0.2% gelatin (3U10 min). The slides were incubated overnight at +4‡C
with the ¢rst antibody diluted in PBS containing 1% BSA. Next day
after 1 h at room temperature the slides were washed in PBS contain-
ing 0.1% BSA, 0.05% saponin and 0.2% gelatin (3U10 min). Endog-
enous peroxidase activity was blocked by incubation for 10 min in
PBS/methanol/(30% H2O2) (8/1/1: vol/vol/vol) before washing in PBS
with 0.1% BSA, 0.05% saponin and 0.2% gelatin (3U10 min). Slides
were then incubated with undiluted EnVision solution from DAKO
(Glostrup, Denmark) for 1 h at room temperature and washed in PBS
with 0.1% BSA, 0.05% saponin and 0.2% gelatin (3U10 min). Positive
reaction was developed for 10 min with DAB chromogen tablets ac-
cording to the manufacturer’s description (DAKO). The slides were
rinsed and washed in 50 mM Tris-HCl, pH 7.6 (2U10 min) then
rinsed in water and counterstained in Mayer’s hematoxylin for 10
min. Rinsing was performed in tap water for 10 min. Finally they
were put for 2 min in various baths with graded ethanol; 70%, 90%,
96%, 99%, 99% and ¢nally xylen (2U2 min). Mounting was per-
formed with Eukitt. The speci¢city of the antibodies was checked
by monitoring a signi¢cant decrease in staining signal with anti-H/
HP preincubated with the peptide used for immunization (SP961010)
and with anti-F preincubated with recombinant hnRNP F. Non-re-
activity of second antibody was checked by replacing the primary
antibody with bu¡er.
3. Results and discussion
3.1. Speci¢c antibodies against the C-terminals of hnRNP
H/HP and hnRNP F
The hnRNPs H, HP and F constitute a recently identi¢ed
subfamily of the hnRNPs possessing unique sequence charac-
teristics [3,4]. The sequence similarity between hnRNPs H and
HP is very high amounting to 96% whereas hnRNPs H and F
and hnRNPs HP and F show similarities of 78% and 75%,
respectively (Fig. 1). The hnRNPs are involved in the metab-
olism of pre-mRNA and some of them shuttle between the
nucleus and the cytoplasm. So far only nuclear functions have
been reported for the hnRNP H, HP and F proteins, however,
the more speci¢c functions of this novel subfamily have not
been investigated in detail. Due to the high degree of sequence
similarity previous reported antibodies against these proteins
show a high degree of cross-reactivity [3,4]. In order to be able
to study the function of each of these proteins in further detail
we set forward the production of speci¢c antibodies against
internal peptides in regions where they show a relatively high
degree of sequence diversity. However, ¢rst, hnRNP H and
hnRNP HP are so closely related that they can hardly be
distinguished immunologically. We therefore concentrated
our e¡ort on the production of two antibodies, one that spe-
ci¢cally recognizes hnRNP H/HP and another that speci¢cally
recognizes hnRNP F.
Sequence comparison reveals that the C-terminal 14 amino
acids of hnRNP H are 86% identical to the corresponding
residues in hnRNP HP and that this peptide is not contained
in hnRNP F (Fig. 1). We therefore used this 14 amino acid C-
terminal peptide of hnRNP H for the production of a poly-
clonal antibody against hnRNP H/HP (anti-H/HP). In order to
make an antibody against hnRNP F we selected a region with
rather low similarity to hnRNP H/HP. The overall identity is
above 75% but at positions Ala384-Val397 a 14 amino acid
peptide shows only 38% identity (Fig. 1) and was thus used
to make a polyclonal antibody against hnRNP F (anti-F). The
antibodies were used for two-dimensional Western blotting.
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However, for proper interpretation of these we ¢rst analyzed
cells transfected with hnRNP H and HP.
3.2. Eukaryotic expression of hnRNP HP and hnRNP H
Fig. 2A shows the two-dimensional gel of L-[35S]-methio-
nine and L-[35S]-cysteine labelled control MRC-5 V2 cells
transfected with the pcDNA3.1 vector devoid of insert and
Fig. 2B shows MRC-5 V2 cells transfected with pcDNA3.1
containing hnRNP HP. As expected and previously shown the
up-regulated hnRNP HP protein migrates in a slightly more
basic position than hnRNP H [6]. Furthermore, careful in-
spection of the gels from the transfected MRC-5 V2 cells
revealed a very slight up-regulation of an approximately 35
kDa protein, termed HPC (Fig. 2B) since it reacts with the C-
terminal anti-H/HP antibody (see Fig. 3). It is thus likely that
HPC represents approximately 35 kDa of the C-terminal of
hnRNP HP (Fig. 1). The up-regulation of HPC in MRC-5
V2 cells, however, was very faint and only apparent after
analysis of COS-1 cells transfected with hnRNP HP since these
cells showed a strong up-regulation of the 35 kDa HPC protein
as seen by comparing Fig. 2C with Fig. 2C. In addition, the
COS-1 cells revealed a strong up-regulation of an approxi-
mately 22 kDa protein which we putatively have termed
HPN presuming that it corresponds to the N-terminal of
hnRNP HP (Fig. 1C). Finally, COS-1 cells transfected with
hnRNP H demonstrated a slight up-regulation of a 35 kDa
protein, termed HC (Fig. 2E and F) since it reacts with the C-
terminal anti-H/HP antibody (see Fig. 3). However, in cells
transfected with hnRNP H we could not detect any strongly
up-regulated 22 kDa protein analogue to HPN, but cannot
exclude the existence of such a protein either.
The up-regulation of the HPC, HC and HPN proteins might
be explained by trans-activation of their genes executed by the
overexpressed proteins, hnRNP H and hnRNP HP, as has
recently been observed with the hnRNP K protein that func-
tions as a transcription factor [18,19]. However, the Western
blots described below show that at least HPC and HC are
formed by proteolytic cleavage of the hnRNP HP and hnRNP
H proteins.
3.3. Two-dimensional Western blotting with anti-H/HP and
anti-F antibodies
Western blots of MRC-5 V2 cells reacted with the two C-
terminal antibodies are shown in Fig. 3. First of all the anti-
H/HP antibody reacts with the hnRNP H and hnRNP HP
proteins which migrate very closely around 55 kDa with
hnRNP H slightly more acidic than hnRNP HP [6]. Two
very weak spots migrating with slightly lower molecular
mass also react with the anti-H/HP antibody as indicated
with arrowheads in Fig. 3B and in the inset in the upper
left corner. All the protein spots shown contain the C-terminal
epitope of hnRNP H/HP (Fig. 1) and are thus likely to repre-
sent various chemical modi¢cations of the proteins. The anti-
H/HP antibody also reacted strongly with the HC protein spot
Fig. 1. Structure of the hnRNP H, hnRNP HP and hnRNP F proteins. Each protein contains three qRRM domains (blue boxes) together with
two auxiliary domains (AUX1 and AUX2, light grey boxes). The positions of the RNP-1 (red), RNP-2 (green), CS-1 (yellow) and CSR-3
(brown) consensus sequences are indicated [3,4,7]. Arrows indicate approximate positions of posttranslational cleavage sites in hnRNPs H and
HP around residue 190^200 giving the HC and HPC proteins and possibly the HPN protein. hnRNP F is not cleaved. The peptides used for anti-
body production are indicated. The anti-H/HP antibody was raised using the SP961010 peptide: 436-VLQENSSDFQSNIA-449 in hnRNP H.
The peptide is 86% identical to the corresponding peptide in hnRNP HP (di¡erent amino acids are underlined). The peptide is not present in
hnRNP F. The anti-F antibody was raised using the SP961174 peptide: 384-AAQATYSGLESQSV-397. Underlined amino acids indicate di¡er-
ences to hnRNP H/HP. hnRNP H and hnRNP HP are very similar and cannot be distinguished by the anti-H/HP antibody.
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localized around 35 kDa as seen in Fig. 3B and as shown by a
separate experiment in Fig. 3D and E. Since the antibody was
raised against a C-terminal peptide of hnRNP H (Fig. 1) we
¢nd that the major spot may correspond to the C-terminal 35
kDa of hnRNP H which we consequently have termed HC
(Fig. 3E). These results thus con¢rmed the above described
transfection studies that HPC and HC represent C-terminal
peptides obtained by proteolytic cleavage of hnRNP HP and
hnRNP H, respectively. In addition to the reaction with the
HC protein (Fig. 3E) we also found reaction with two spots
migrating with slightly lower molecular mass (arrowheads in
Fig. 3E) in analogy with the reaction with the uncleaved
hnRNP H and hnRNP HP proteins (stippled box, upper left
corner, Fig. 3B). These lower molecular mass proteins are
analogously likely to represent low levels of modi¢ed versions
of the C-terminal of hnRNP H. This may also apply to the
very low levels of the protein indicated with a question mark
(Fig. 2D and E).
The anti-F antibody speci¢cally reacts with the hnRNP F
protein as seen by the blot in Fig. 2C. Thus there is no in-
dication of the presence of proteolytic cleavage products of
hnRNP F.
A fact that strengthens the cleavage hypothesis is that the
approximate sum of molecular masses of HPC (35 kDa) and
HPN (22 kDa) is close to the total molecular mass of hnRNP
HP (55 kDa). Secondly, from the deduced sequence of the
hnRNP HP protein it can be calculated that if it is cleaved
around amino acid number 190^200 the expected molecular
masses and pIs of the obtained products are in agreement
with the observed positions of the proteins in the two-dimen-
sional gels, i.e. for HPC we calculated a molecular mass of
about 26^28 kDa and a pI of about 5.1^5.7 and for HPN a
deduced molecular mass of about 22^23 kDa and a pI of
about 6.1^7.3. The two-dimensional gels thus con¢rm that
HPC has a higher molecular mass than HPN and migrates in
a more acidic position than HPN (Fig. 2).
3.4. Structure of the cleavage products
The up-regulation of the HC, HPC and possibly the HPN
protein in the transfected cells may thus be explained by pro-
teolytic cleavage of the overexpressed hnRNP H and hnRNP
HP proteins. Overexpression is not necessary for cleavage since
the HC and HPC proteins could be demonstrated by Western
blotting of both normal and transformed MRC-5 ¢broblasts
(not shown). It could be argued that the functional signi¢-
cance of cleaving the hnRNP H/HP proteins would be to in-
activate them. However, cleavage of hnRNP HP around ami-
no acid number 190^200 gives the HPC protein two auxiliary
domains together with the qRRM3 domain and the putative
HPN protein two qRRM domains (see Fig. 1). The structure of
Fig. 2. Two-dimensional gels of labelled and transfected MRC-5 V2 ¢broblasts (A, B) and COS-1 cells (C^F). Cells transfected with the
pcDNA3.1 vector containing insert is indicated with (+hnRNP H or +hnRNP HP) while control cells transfected with the pcDNA3.1 vector
without insert is indicated with (3hnRNP H or 3hnRNP HP). As expected the position of the hnRNP HP is slightly basic to the hnRNP H
protein [6] seen by comparing the hnRNP HP transfected cells (B) with the controls (A). Furthermore, a slight up-regulation was also seen of
an approximately 35 kDa protein putatively assigned HPC since it is recognized by the C-terminal anti-H/HP antibody (see Fig. 3). Up-regula-
tion of the HPC protein, however, is much more apparent in hnRNP HP transfected COS-1 cells (C, D). Insets in C and D show results from a
separate experiment. Another approximately 22 kDa protein putatively assigned HPN was also found to be markedly up-regulated in COS-1
cells transfected with hnRNP HP. This protein presumably corresponds to the N-terminal of hnRNP HP. Finally, in COS-1 cells transfected
with hnRNP H a slight up-regulation of the approximately 35 kDa HC protein was seen (E, F). HC is recognized by the C-terminal anti-H/HP
antibody (see Fig. 3). The acidic and basic side of the isoelectric focusing is indicated as well as the approximate molecular masses.
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the HPN protein would thus resemble the UP 1 protein that is
obtained by proteolytic cleavage of another heterogeneous
nuclear ribonucleoprotein, hnRNP A1 [20]. The UP 1 protein
consists of the 195 N-terminal residues of hnRNP A1 contain-
ing two RRM domains and besides possessing a nucleic acid
helix-destabilizing e¡ect [20,21] it has also been reported to
stimulate the activity of DNA polymerase K [20,22] an activity
which is not contained in the hnRNP A1 protein itself [20]. It
is thus likely that some of the cleavage products do have
functions of their own. Further studies, however, are required
in order to reveal the physiological role of these posttransla-
tional modi¢cations as well as those previously described such
as phosphorylations [4] and methylations [23]. Finally, it
should be stressed that we have positive evidence for the re-
latedness between HPC and hnRNP HP and between HC and
hnRNP H but not between HPN and hnRNP HP. We cannot
exclude the possibility that HPN actually represents a protein
trans-activated by HPC or hnRNP HP. The level present of this
protein as judged by silverstaining of the gels, however, is so
low that a separate identi¢cation using, e.g. mass spectrome-
try becomes very di⁄cult. Also, we unfortunately failed to
produce a successful antibody against the N-terminal (Lys35-
Arg44) of hnRNP H.
3.5. Subcellular localization of hnRNP H/HP and hnRNP F
in various tissues
We further used the speci¢c antibodies to reveal the sub-
cellular localization of each of the hnRNPs by immunohisto-
chemical analyses of a variety of normal and tumor tissues. In
all tissues examined we observed that the main subcellular
localization of hnRNP H/HP always was in the nucleus. Fig.
4 shows examples of this in the strati¢ed squamous epithelium
of the uterine cervix (Fig. 4A and E), in the pseudostrati¢ed
columnar epithelium of the endometrium (Fig. 4G), in the
islets of Langerhans (Fig. 4I), in smooth muscle cells (Fig.
4K) as well as in nerve cells (Fig. 4M). The hnRNP F protein
on the contrary localizes entirely di¡erent. In the strati¢ed
squamous epithelium of the uterine cervix (Fig. 4C) the nuclei
of cells in the basal layers stain strongly whereas the cyto-
plasm apparently contains only very low amounts (black ar-
rows, Fig. 4C). As the cells move towards the super¢cial
layers increasing amounts apparently accumulate in the cyto-
Fig. 3. Two-dimensional Western blots of MRC-5 V2 ¢broblasts. The labelled blot is shown in A. B shows the Western blots reacted with
anti-H/HP and C shows the blot reacted with anti-F. The positions of hnRNPs H, HP and F are indicated with arrows. The stippled box in
upper left corner (A, B) is a magni¢cation of the hnRNP H and hnRNP HP region. Arrowheads show two reacting proteins migrating with
slightly lower molecular mass. Central stippled box shows the 35 kDa HC protein that reacts with the C-terminal anti-H/HP (as seen in B).
This central area is shown magni¢ed from a di¡erent experiment in D (labelled) and in E (anti-H/HP blot). In the magni¢cation it is seen that
two faint proteins (arrowheads), likely to represent modi¢cations of HC, with lower molecular masses react with the C-terminal anti-H/HP anti-
body. The question mark indicates a faint reaction with an unknown protein also likely to represent a modi¢cation of HC. C shows the West-
ern blot reacted with anti-F. Only the hnRNP F protein reacts with the C-terminal anti-F antibody with no evidence of the presence of cleav-
age products. The acidic and basic side of the isoelectric focusing is indicated as well as the approximate molecular masses.
C
Fig. 4. Immunoperoxidase staining of various normal and pathological tissues. Strati¢ed squamous epithelium (planocellular carcinoma) of the
uterine cervix (A^F), pseudostrati¢ed columnar epithelium (adenocarcinoma) of the endometrium (G, H), islets of Langerhans (I, J), smooth
muscle cells (K, L) and nerve cells (M, N). hnRNP H/HP is almost exclusively localized to the nuclei as exempli¢ed with the arrows in A, E,
G, I, K, M. B is a control to A where the anti-H/HP antibody prior to analysis has been preincubated with the peptide (SP961010) used for im-
munization. hnRNP F shows a quite di¡erent localization in the same tissues. In the strati¢ed squamous epithelium hnRNP F localizes to the
nuclei of the cells in the basal layers of the epithelium (black arrows, C) while increasingly more hnRNP F protein localize to the cytoplasm as
the cells move toward the super¢cial layers as illustrated by the white arrows (C). D is a control to C where the antibody prior to analysis has
been preincubated with recombinant hnRNP F. F shows a close view of the cells in the epithelial layer of C showing a rather even distribution
of hnRNP F between the nucleus and the cytoplasm. In the pseudostrati¢ed columnar epithelium (adenocarcinoma) of the endometrium (H) as
well as in the islets of Langerhans (J) an even distribution is observed with hnRNP F localized in the cytoplasm as well as in the nucleus. In
smooth muscle cells (L) and in nerve cells (N) hnRNP F is apparently localized predominantly in the cytoplasm with modest amounts present
in the nucleus.
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plasm so that a more even distribution is seen between the
nucleus and the cytoplasm (white arrows, Fig. 4C and F). An
even distribution between the nucleus and the cytoplasm is
also apparent in the pseudostrati¢ed columnar epithelium of
the endometrium (Fig. 4H) as well as in the islets of Langer-
hans (Fig. 4J). In smooth muscle cells (Fig. 4L) and in nerve
cells (Fig. 4N) hnRNP F apparently distributes so that the
main part is localized in the cytoplasm with more modest
amounts present in the nucleus. The present results largely
con¢rm and extend those reported by Matunis et al. [3] who
used a monoclonal antibody that recognizes hnRNPs F and H
(and presumably HP) and with immuno£uorescence observed
a localization mainly distributed in the nucleus but also to a
certain extend in the cytoplasm of HeLa cells. In the light of
our results it seems that the cytoplasmic staining is largely due
to the hnRNP F antigen and the nuclear staining may be the
result of the presence of both hnRNP F and hnRNP H/HP.
Using a laser scanning confocal microscope they found the
antigen to be concentrated in discrete regions in addition to
having a di¡use nucleoplasmic localization of resemblance,
although di¡erent, to the ‘speckled’ staining pattern observed
with an antibody to snRNP [3].
In summary, the large majority of the hnRNP H/HP anti-
gens are thus localized in the nucleus, indicating that the main
functions of these two hnRNPs are within the nucleus. This is
in line with the observation that both are common nuclear
matrix proteins [6] and possess several functions that are per-
formed in the nucleus, including participation in splicing [8,9]
and pre-mRNA cleavage and polyadenylation [7]. The
hnRNP F antigen, on the other hand, besides being present
in the nucleus is also found in signi¢cant quantities in the
cytoplasm in a number of tissues. It is thus likely that besides
the previously identi¢ed nuclear functions of hnRNP F, i.e.
participation in pre-mRNA splicing [10,11] and interaction
with the nuclear cap binding protein complex, CBC [11] it
may also possess cytoplasmic functions due to the signi¢cant
quantities of the protein localized here (Fig. 4C, F, H, J, L
and N).
3.6. Conclusion
In conclusion, we have identi¢ed a number of di¡erences in
the fate of the very closely sequence related hnRNPs H, HP
and F. hnRNP H and hnRNP HP are subjected to posttrans-
lational cleavage where the resulting proteins may have func-
tions on their own. Furthermore, the di¡erences in the sub-
cellular distribution of the proteins with hnRNP H/HP more
strictly localized in the nucleus while hnRNP F shows a local-
ization that varies from a predominant nuclear presence to a
predominant cytoplasmic presence dependent on the speci¢c
cell type may re£ect di¡erences in their functions. The func-
tional signi¢cance of these di¡erences now need to be inves-
tigated in further detail.
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